Market research and consulting
Custom research and consultancy to answer your business questions
Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases.
Consumer health and nutritionals
We combine our knowledge of the pharmaceutical sector with our understanding of patients, physicians and consumers to deliver integrated insights.
We have a wealth of experience with medical devices, in vitro and in vivo diagnostics, imaging equipment and e-health solutions. We use our knowledge of the unique market dynamics and regulatory nature of this sector to improve client understanding.
We also offer real-world insights with our range of cost-effective sydicated solutions:
Immunology, Virology, Oncology, Nephrology, Cardiovascular and others
Our online syndicated tracking programme provides global marketing teams with real-time access to the key dynamics driving their market. Using appropriately designed physician panels, we provide patient chart data for a broad range of therapeutic areas and geographies.
Immunology, Atopic Dermatitis, Chronic Pain, Diabetes, NASH and others
Our patient report series offer fresh insight into the behaviour, attitudes and needs of people living with different types of chronic illness, providing a map of the patient journey from pre-diagnosis to stabilisation.
- Some example case studiesHow we adapted our conference research to a virtual setting to measure performance and reactions
The challengeIn 2020, due to the pandemic, several key medical conferences went virtual and offered a complete digital experience which constituted a novel challenge for the pharmaceutical industry. Our client was presenting clinical trial data for their cardiovascular product and were also exhibiting a virtual booth at the ESC (European Society of Cardiology) Congress 2020 – The digital Experience. They wanted to understand reactions to…read more »How a two-phase evaluation involving interactive workshops gave guidance for improving a Patient Assistance Programme in CV
The challengeOur client had launched a self-injection treatment for cardiovascular conditions and were creating an accompanying Patient Assistance Programme (PAP) to educate patients in the use and uptake of this product. The client wanted to understand how successful the PAP was at meeting the needs of patients, trainers and prescribers, and whether it positively differentiated them from competitors. They wanted to evaluate each individual component…read more »How we helped to enrich the understanding of value message trade-off choices made by payers in the psoriasis market
The challenge:our client’s global market access team was preparing value message themes and statements for their new Psoriasis treatment. In order to help prepare them for a successful competitive launch, research was required to better understand the strength and resonance of those statements and themes with payers and to identify the best language and prioritisation for each payer archetype. The solution:We began by reviewing secondary…read more »
- Our latest white papersThe impact of COVID-19 on chronic disease management and the implications for pharma marketing
On February 11, 2020, COVID-19 was officially named by the World Health Organisation (WHO). Since then the novel coronavirus causing it, (a severe acute respiratory syndrome) has left its mark on almost every country in the world.read more »China: How to strategise and win in the world's fastest changing healthcare market
In this paper, our experts Marc Yates, Pei Li Teh and Brett Gardiner discuss the China healthcare reforms which affect pharma and propose how to build the market understanding required to launch a brand effectively in this exciting region.read more »